Image

Middle East and Africa Intraoperative Radiation Therapy Market – Industry Trends and Forecast to 2028

  • Medical Devices
  • Published Report
  • Aug 2021
  • MEA
  • 350 Pages
  • No of Tables: 129
  • No of Figures: 25
  • Medical Devices
  • Published Report
  • Aug 2021
  • MEA
  • 350 Pages
  • No of Tables: 129
  • No of Figures: 25

By method (into electron IORT, intraoperative brachytherapy, high dose-rate IORT, X-ray IORT and others.), product (intraoperative radiation therapy devices, intraoperative radiation therapy accessories and software & services) type(portable and benchtop), application (breast cancer, brain tumor, head & neck cancer, soft tissue sarcoma, pediatric tumors, gynecological cancer, genitourinary cancers, upper gastro-intestinal tumors other cancer) end user (hospital, ambulatory surgical centers, specialty center and others) and distribution channel (direct tender and retail sales) Country (South Africa, Saudi Arabia, UAE, Egypt, Israel, and Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Middle East and Africa Intraoperative Radiation Therapy Market Market Analysis and Insights: Middle East and Africa Intraoperative Radiation Therapy Market

Middle East and Africa Intraoperative Radiation Therapy Market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.1% in the forecast period of 2021 to 2028 and is expected to reach USD 17.31 million by 2028.  Increasing demand for Intraoperative radiation therapy in the medical industry is a major driver expected to boost growth of the Middle East and Africa Intraoperative radiation therapy market.

Intraoperative Radiotherapy (IORT) is a technique that involves delivery of a high dose of ionizing radiation to the tumor or tumor bed during surgery. It involves direct visualization of the tumor bed and spaces out normal tissues from the tumor bed that allows maximization of dose to the tumor while minimizing the dose to normal tissues. Thus, IORT is capable of delivering higher total effective dose to the tumor bed and facilitate dose escalation without significantly increasing normal tissue complications and improve therapeutic ratio.

Because IORT radiation is targeted right at the tumor, the dose can be up to 2½ times higher than a safe dose of traditional radiation. This helps in keeping cancer from coming back in the same place. IORT has demonstrated its efficacy in a wide variety of tumors and cancers such as recurrent colorectal cancers, recurrent gynecological cancers and soft-tissue tumours. Recently, it has emerged as a popular treatment option for selected, early-stage breast cancer, owing to its ability to complete the entire course of radiotherapy during surgery.

Factors driving the growth of the intraoperative radiation therapy market are increase in older population above 60 year, and advancement of modern sophisticated technology in IORT market such as artificial intelligence. On the other hand, risk associated with high dose radiation exposure such as skin problem and fatigue, and challenges associated with brand equity may restrain the market growth. Increasing research studies and clinical trials for safety and efficacy over the use of IORT in treating cancer and growing application of IORT in various cancer treatment such as breast cancer and brain tumor are opportunities in the market.

High competition among key players challenges the market growth acts as a challenge in the growth of market. I

This Middle East and Africa intraoperative radiation therapy market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Middle East and Africa Intraoperative Radiation Therapy Market Middle East and Africa Intraoperative radiation therapy Market Scope and Market Size

Middle East and Africa Intraoperative radiation therapy market is segmented on the basis of method, product, type, application, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of method, the intraoperative radiation therapy market is segmented into electron IORT, intraoperative brachytherapy, high dose-rate IORT, X-ray IORT, and others.  In 2021, X-ray IORT segment is expected to dominate the market due to greater usage of X-ray IORT in delivering single high dose rate of X-Ray
  • On the basis of product, the intraoperative radiation therapy market is segmented into intraoperative radiation therapy devices, intraoperative radiation therapy accessories, and software & services. In 2021, intraoperative radiation therapy devices segment is expected to dominate the intraoperative radiation therapy market as it is the most widely used equipment for IORT delivery of intraoperative X ray
  • On the basis of type, the intraoperative radiation therapy market is segmented into portable and benchtop. In 2021, portable segment is expected to dominate the market as it can be carried to any place and does not require much effort.
  • On the basis of application, the intraoperative radiation therapy market is segmented into breast cancer, brain tumor, head & neck cancer, soft tissue sarcoma, pediatric tumors, gynecological cancer, genitourinary cancers, upper gastro-intestinal tumors, and other cancers. In 2021, breast cancer segment is expected to dominate the market due to growing prevalence of breast cancer in women in the region.
  • On the basis of end user, the intraoperative radiation therapy market is segmented into hospital, ambulatory surgical centers, specialty centers, and others. In 2021, hospital segment is expected to dominate the market due to growing number of hospitals in the region.
  • On the basis of distribution channel, the intraoperative radiation therapy market is segmented into direct tender and retail sales. In 2021, the direct tender segment is expected to dominate the market as it is a quick and easy way to purchase the equipment.

Middle East and Africa Intraoperative radiation therapy Market: Country Level Analysis

The Middle East and Africa intraoperative radiation therapy market is analyzed and market size information is provided by method, product, type, application, end user, and distribution channel as referenced above.

Countries covered in the Middle East and Africa intraoperative radiation therapy market report are South Africa, Saudi Arabia, UAE, Egypt, Israel, and Rest of Middle East and Africa

South Africa is dominating the Middle East and Africa intraoperative radiation therapy market with highest CAGR and largest market share due to increase number of technological product launches by the major manufacturers in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa Intraoperative radiation therapy brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Rising Demand of Intraoperative radiation therapy in Medical Industry

Middle East and Africa intraoperative radiation therapy market also provides you with detailed market analysis for every country growth in industry with sales, components sales, impact of technological development in intraoperative radiation therapy and changes in regulatory scenarios with their support for the intraoperative radiation therapy  market. The data is available for historic period 2010-2019.

Competitive Landscape and Middle East and Africa Intraoperative radiation therapy Market Share Analysis

Middle East and Africa intraoperative radiation therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, India presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided are only related to the companies’ focus related to Middle East and Africa intraoperative radiation therapy market.

Some of the major players operating in the intraoperative radiation therapy market are IntraOp Medical, Inc., Ariane Medical Systems Ltd, Varian Medical Systems, Inc., Carl Zeiss MEDITECAG, Eckert & Ziegler. , Sensus Healthcare Inc, iCAD Inc., Elekta AB, SIT - S.I.T. Sordina IORT Technologies S.p.A., REMEDI Co., Ltd., GMV INNOVATING SOLUTIONS,  Brainlab, AG and others.

Global intraoperative radiation therapy market is fragmented and major players have used various strategies such as collaboration, recognition, agreements, and others to increase their footprints in the intraoperative radiation therapy market.

For instance,

  • In April 2021, Varian Medical Systems, Inc.  signed an agreement with Australia's Icon Group to provide 30 linear accelerators and associated treatment software to fight global cancer burden. This will help the company to increase in access to care across regional and underserviced areas in Australia and Asia.
  • In October 2020, IntraOp Medical, Inc. and University of Verona in Italy announced the enrollment of the first patient in the PancFORT Trial. This helped the company to advance the science and clinical evidence supporting the role of IORT in treating this dreadful disease.


SKU-

Why Choose Us


Frequently Asked Questions